PMID- 30840079 OWN - NLM STAT- MEDLINE DCOM- 20200226 LR - 20220409 IS - 1527-974X (Electronic) IS - 1067-5027 (Print) IS - 1067-5027 (Linking) VI - 26 IP - 4 DP - 2019 Apr 1 TI - Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). PG - 276-285 LID - 10.1093/jamia/ocy169 [doi] AB - OBJECTIVE: The study sought to describe patient-entered supplemental information on symptomatic adverse events (AEs) in cancer clinical research reported via a National Cancer Institute software system and examine the feasibility of mapping these entries to established terminologies. MATERIALS AND METHODS: Patients in 3 multicenter trials electronically completed surveys during cancer treatment. Each survey included a prespecified subset of items from the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Upon completion of the survey items, patients could add supplemental symptomatic AE information in a free text box. As patients typed into the box, structured dropdown terms could be selected from the PRO-CTCAE item library or Medical Dictionary for Regulatory Activities (MedDRA), or patients could type unstructured free text for submission. RESULTS: Data were pooled from 1760 participants (48% women; 78% White) who completed 8892 surveys, of which 2387 (26.8%) included supplemental symptomatic AE information. Overall, 1024 (58%) patients entered supplemental information at least once, with an average of 2.3 per patient per study. This encompassed 1474 of 8892 (16.6%) dropdowns and 913 of 8892 (10.3%) unstructured free text entries. One-third of the unstructured free text entries (32%) could be mapped post hoc to a PRO-CTCAE term and 68% to a MedDRA term. DISCUSSION: Participants frequently added supplemental information beyond study-specific survey items. Almost half selected a structured dropdown term, although many opted to submit unstructured free text entries. Most free text entries could be mapped post hoc to PRO-CTCAE or MedDRA terms, suggesting opportunities to enhance the system to perform real-time mapping for AE reporting. CONCLUSIONS: Patient reporting of symptomatic AEs using a text box functionality with mapping to existing terminologies is both feasible and informative. CI - (c) The Author(s) 2019. Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For permissions, please email: journals.permissions@oup.com. FAU - Chung, Arlene E AU - Chung AE AD - Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA. AD - Program on Health and Clinical Informatics, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA. AD - Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. FAU - Shoenbill, Kimberly AU - Shoenbill K AD - Program on Health and Clinical Informatics, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA. AD - Department of Family Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA. FAU - Mitchell, Sandra A AU - Mitchell SA AD - National Cancer Institute, Rockville, Maryland, USA. FAU - Dueck, Amylou C AU - Dueck AC AD - Alliance Statistics and Data Center, Mayo Clinic, Scottsdale, Arizona, USA. FAU - Schrag, Deborah AU - Schrag D AD - Division of Population Sciences, Department of Medical Oncology, Dana-Farber/Harvard Cancer Center, Brookline, Massachusetts, USA. FAU - Bruner, Deborah W AU - Bruner DW AD - Nell Hodgson Woodruff School of Nursing, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA. FAU - Minasian, Lori M AU - Minasian LM AD - National Cancer Institute, Rockville, Maryland, USA. FAU - St Germain, Diane AU - St Germain D AD - National Cancer Institute, Rockville, Maryland, USA. FAU - O'Mara, Ann M AU - O'Mara AM AD - National Cancer Institute, Rockville, Maryland, USA. FAU - Baumgartner, Paul AU - Baumgartner P AD - Semantic Bits, LLC, Herndon, Virginia, USA. FAU - Rogak, Lauren J AU - Rogak LJ AD - Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA. FAU - Abernethy, Amy P AU - Abernethy AP AD - Department of Medicine, Duke Cancer Institute, Durham, North Carolina, USA. AD - Flatiron Health, New York, New York, USA. FAU - Griffin, Ashley C AU - Griffin AC AD - Program on Health and Clinical Informatics, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA. FAU - Basch, Ethan M AU - Basch EM AD - Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA. AD - Program on Health and Clinical Informatics, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA. AD - Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. AD - Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA. LA - eng GR - HHSN261201000063C/CA/NCI NIH HHS/United States GR - HHSN261201000043C/CA/NCI NIH HHS/United States GR - P30 CA016086/CA/NCI NIH HHS/United States GR - P30 CA008748/CA/NCI NIH HHS/United States GR - KL2 TR001109/TR/NCATS NIH HHS/United States GR - T15 LM012500/LM/NLM NIH HHS/United States PT - Journal Article PT - Multicenter Study PT - Research Support, N.I.H., Extramural PL - England TA - J Am Med Inform Assoc JT - Journal of the American Medical Informatics Association : JAMIA JID - 9430800 RN - 0 (Antineoplastic Agents) SB - IM MH - Adult MH - Adverse Drug Reaction Reporting Systems MH - Aged MH - Aged, 80 and over MH - Antineoplastic Agents/*adverse effects MH - Drug Evaluation MH - *Drug-Related Side Effects and Adverse Reactions MH - Female MH - Humans MH - Internet MH - Male MH - Middle Aged MH - National Cancer Institute (U.S.) MH - Neoplasms/*drug therapy MH - *Patient Reported Outcome Measures MH - Self Report MH - *Software MH - United States MH - User-Computer Interface PMC - PMC6402312 OTO - NOTNLM OT - MedDRA OT - PRO-CTCAE OT - free text OT - patient-reported outcomes OT - symptomatic adverse events EDAT- 2019/03/07 06:00 MHDA- 2020/02/27 06:00 PMCR- 2020/02/20 CRDT- 2019/03/07 06:00 PHST- 2018/05/03 00:00 [received] PHST- 2018/10/17 00:00 [revised] PHST- 2018/11/26 00:00 [accepted] PHST- 2019/03/07 06:00 [entrez] PHST- 2019/03/07 06:00 [pubmed] PHST- 2020/02/27 06:00 [medline] PHST- 2020/02/20 00:00 [pmc-release] AID - 5320658 [pii] AID - ocy169 [pii] AID - 10.1093/jamia/ocy169 [doi] PST - ppublish SO - J Am Med Inform Assoc. 2019 Apr 1;26(4):276-285. doi: 10.1093/jamia/ocy169.